Evidence map›Paper›PMID 35226708›Full record

Trial reportPloS one2022

COVID-19 vaccine acceptance and rejection in an adult population in Bosnia and Herzegovina.

Adnan Fojnica, Ahmed Osmanovic, Nermin Đuzic, Armin Fejzic, Ensar Mekic, Zehra Gromilic, Imer Muhovic, Amina Kurtovic-Kozaric

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Changes in management of head and neck malignancies during the COVID-19 pandemic.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Adnan FojnicaInstitute of Biochemistry, Graz University of Technology, Graz, Austria.
Ahmed OsmanovicOlawell Inc., Manchester, Massachusetts, United States of America.ORCID 0000-0002-0553-6520
Nermin ĐuzicInternational Burch University, Sarajevo, Bosnia and Herzegovina.ORCID 0000-0003-1091-1978
Armin FejzicDepartment of Molecular biology, University of Vienna, Vienna, Austria.
Ensar MekicInternational Burch University, Sarajevo, Bosnia and Herzegovina.
Zehra GromilicInstitute of Biochemistry, Graz University of Technology, Graz, Austria.
Imer MuhovicInternational Burch University, Sarajevo, Bosnia and Herzegovina.
Amina Kurtovic-KozaricInternational Burch University, Sarajevo, Bosnia and Herzegovina.ORCID 0000-0002-6063-7260
International Burch University · BAGraz University of Technology · ATScientists Center for Animal Welfare · USUniversity of Sarajevo · BAUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBosnia and Herzegovina is among ten countries in the world with the highest mortality rate due to COVID-19. Lack of lockdown, open borders, high mortality rate, no vaccination plan, and strong domestic anti-vaccination movement present serious COVID-19 concerns in Bosnia and Herzegovina. In such circumstances, we set out to study 1) the willingness of general public to receive the vaccine, 2) factors that affect vaccine rejection, and 3) motivation for vaccine acceptance.

methodsA cross-sectional study was conducted among 10471 adults in Bosnia and Herzegovina to assess the acceptance or rejection of participants toward COVID-19 vaccination. Using a logistic regression model, we examined the associations of sociodemographic characteristics with vaccine rejection, reasons for vaccine hesitancy, preferred vaccine manufacturer, and information sources.

resultsSurprisingly, only 25.7% of respondents indicated they would like to get a COVID-19 vaccine, while 74.3% of respondents were either hesitant or completely rejected vaccination. The vaccine acceptance increased with increasing age, education, and income level. Major motivation of pro-vaccination behavior was intention to achieve collective immunity (30.1%), while the leading incentive for vaccine refusal was deficiency of clinical data (30.2%). The Pfizer-BioNTech vaccine is shown to be eightfold more preferred vaccine compared to the other manufacturers. For the first time in Bosnia, vaccine acceptance among health care professionals has been reported, where only 39.4% of healthcare professionals expressed willingness to get vaccinated.

conclusionWith the high share of the population unwilling to vaccinate, governmental impotence in securing the vaccines supplies, combined with the lack of any lockdown measures suggests that Bosnia and Herzegovina is unlikely to put COVID-19 pandemic under control in near future.

Indexed as

COVID-19Medication AdherenceSARS-CoV-2Vaccination RefusalAdolescentAdultAgedBosnia and HerzegovinaCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansMaleMiddle AgedPandemicsCOVID-19 Vaccines

Identifiers

PMID35226708
PMCPMC8884480
OpenAlexW4214836700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.